Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Symptoms, Doctors, Treatments, Advances & More

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Overview

Save information for later
Sign Up

Learn About Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Local Doctors?
Elite in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Otolaryngology
Elite in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Otolaryngology
675 N St Clair St Ste 15-200, Galter Pavilion, 
Chicago, IL 
Experience:
22+ years
Languages Spoken:
English
Offers Telehealth

Bruce Tan is an Otolaryngologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 22 years. Dr. Tan is rated as an Elite provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Nasal Polyps, Sinusitis, Endoscopy, and Nerve Decompression. Dr. Tan is board certified in American Board Of Otolaryngology-Head And Neck Surgery - Otolaryngology - Head And Neck Surgery (Certified).

Elite in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Otolaryngology
Elite in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Otolaryngology
675 N St Clair St Ste 15-200, Galter Pavilion, 
Chicago, IL 
Experience:
41+ years
Languages Spoken:
English
Offers Telehealth

Robert Kern is an Otolaryngologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 41 years. Dr. Kern is rated as an Elite provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Nasal Polyps, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Asthma, Endoscopy, and Nerve Decompression. Dr. Kern is board certified in American Board Of Otolaryngology-Head And Neck Surgery - Otolaryngology - Head And Neck Surgery (Certified).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Otolaryngology
Elite in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Otolaryngology
675 N St Clair St Ste 15-200, Galter Pavilion, 
Chicago, IL 
Experience:
37+ years
Languages Spoken:
English
Offers Telehealth

David Conley is an Otolaryngologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 37 years. Dr. Conley is rated as an Elite provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Nasal Polyps, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Asthma, Endoscopy, and Nerve Decompression. Dr. Conley is board certified in American Board Of Otolaryngology-Head And Neck Surgery - Otolaryngology - Head And Neck Surgery (Certified).

What are the latest Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Clinical Trials?
A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study

Summary: This is a single-arm extension study to investigate the long-term safety, tolerability, and efficacy of lunsekimig in adult participants with inadequately controlled CRSwNP who have completed a previous lunsekimig CRSwNP clinical study (also referred to as the parent study ACT18207). The study duration will be up to approximately 56 weeks per participant, 52 weeks of treatment period, and 4 weeks ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Phase 3 Trial to Investigate the Efficacy, Safety, and Tolerability of Itepekimab in Adult Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Summary: EFC18418 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 3 study with 3 treatment groups. The purpose of the study is to evaluate the efficacy, safety and tolerability of 2 dosing regimens of itepekimab compared to placebo as add-on therapy to intranasal corticosteroids (INCS) in male and female participants with chronic rhinosinusitis with nasal polyps (CRS...